- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Safety Markers of Adjuvanted Influenza Vaccine
Total 19 results
-
University Hospital, GhentGlaxoSmithKline; Novartis Vaccines; University of Surrey; Innovative Medicines... and other collaboratorsCompletedSafety Markers of Adjuvanted Influenza VaccineBelgium
-
Butantan InstituteUniversity of Sao Paulo; Insituto Adolfo Lutz; Centro de Referencia e Treinamento...CompletedImmunocompromised Patients | Safety of Pandemic Influenza A (H1N1)Vaccine | Immunogenicity of Pandemic Influenza A (H1N1)VaccineBrazil
-
Centers for Disease Control and Prevention, ChinaRecruitingPneumococcal Vaccines | Safety | Influenza Vaccines | COVID-19 Vaccines | Immunogenicity, VaccineChina
-
Chulalongkorn UniversityHIV-NAT, Thai Red Cross - AIDS Research Centre; Chula Clinical Research Center...RecruitingSafety of a Single Dose of COMVIGEN Vaccine | Reactogenicity of a Single Dose of COMVIGEN Vaccine | Immunogenicity of a Single Dose of COMVIGEN Vaccine | Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Immunogenicity...Thailand
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... and other collaboratorsRecruitingSafety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine | Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine | Immune Response... and other conditionsThailand
-
Ology BioservicesCompletedPhase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza VaccineUnited States
-
Cancer Institute and Hospital, Chinese Academy...Beijing Chaoyang District Centre for Disease Control and Prevention; Neimenggu...UnknownSafety of Inactivated EV71 Vaccine | Immunization of Inactivated EV71 VaccineChina
-
Imperial College LondonPublic Health EnglandCompletedInfluenza Vaccines Efficacy and SafetyUnited Kingdom
-
Novartis VaccinesCompletedProphylaxis of Avian Influenza VaccineUnited Kingdom
-
Jiangsu Province Centers for Disease Control and...CompletedSafety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules)
-
Peking UniversityShandong University; Fudan University; Centers for Disease Control and Prevention...CompletedInfluenza, Human | Health Knowledge, Attitudes, Practice | Influenza Vaccines | Cost of Illness | Immunization ProgramsChina
-
Jiaxing AnDiCon Biotech Co.,LtdRecruitingSafety Issues | Effect of DrugChina
-
Butantan InstituteCompletedRNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Physiological Effects of Drugs | VaccinesBrazil
-
Heinrich-Heine University, DuesseldorfRecruitingMultiple Sclerosis, Relapsing-Remitting | Vaccine Response ImpairedGermany
-
University of California, Los AngelesUniversity of Colorado, Denver; National Institute of Allergy and Infectious... and other collaboratorsCompletedRNA Virus Infections | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Respiratory Tract Disease | Virus Disease | Physiological Effects of Drugs | VaccinesUnited States
-
National Cheng-Kung University HospitalUnknownChronic Kidney Disease | Immunogenicity and Adverse Drug Effect of Vaccines InfluenzaTaiwan
-
Zhejiang Provincial Center for Disease Control...RecruitingImmunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential ImmunizationChina
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedThe Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and InfantsChina
-
Neuroganics LLCRamos Injury Law FirmRecruitingCOVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Vasculitis | Neuritis | Thrombocytopenia | Influenza | Corona Virus Infection | Blood Clot | Guillain-Barré | Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use | GWAS | Genetic SequencingUnited States